Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Fillet

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Acyclovir-resistance zona in a immunocompromised HIV seronegative patient]A Lesueur, A M Fillet, D Bouscary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2000
Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study GroupD Salmon-Céron, A M Fillet, J P Aboulker, et al.
AIDS (London, England)|April 26, 2000
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patientsB M Anduze-Faris, A M Fillet, J Gozlan, et al.
AIDS (London, England)|February 24, 2001
Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapyM Jouan, M Savès, R Tubiana, et al.
AIDS (London, England)|June 15, 2000
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapyD Salmon-Céron, M C Mazeron, S Chaput, et al.
Journal of Medical Virology|June 29, 2004
Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infectionS Alain, S Hantz, C Scieux, et al.
Vox Sanguinis|August 27, 2016
International Forum regarding practices related to donor haemoglobin and ironM Goldman, K Magnussen, J Gorlin, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Annales De Dermatologie Et De Venereologie|September 25, 1998
[Acyclovir-resistance zona in a immunocompromised HIV seronegative patient]A Lesueur, A M Fillet, D Bouscary, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2000
Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study GroupD Salmon-Céron, A M Fillet, J P Aboulker, et al.
AIDS (London, England)|April 26, 2000
Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patientsB M Anduze-Faris, A M Fillet, J Gozlan, et al.
AIDS (London, England)|February 24, 2001
Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapyM Jouan, M Savès, R Tubiana, et al.
AIDS (London, England)|June 15, 2000
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapyD Salmon-Céron, M C Mazeron, S Chaput, et al.
Journal of Medical Virology|June 29, 2004
Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infectionS Alain, S Hantz, C Scieux, et al.
Vox Sanguinis|August 27, 2016
International Forum regarding practices related to donor haemoglobin and ironM Goldman, K Magnussen, J Gorlin, et al.
Pageof 5